Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Dan Liu, Qing Song, Yuqin Zeng, Rong Yi, Yi Liu, Xin Li, Yan Chen, Shan Cai & Ping Chen. (2023) The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1741-1751.
Read now
Read now
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton & Afisi S Ismaila. (2023) Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 719-731.
Read now
Read now
Qing Song, Ling Lin, Aiyuan Zhou, Wei Cheng, Cong Liu, Yating Peng, Zijing Zhou, Yuqin Zeng, Dingding Deng, Dan Liu, Zhiping Yu, Yan Chen, Shan Cai & Ping Chen. (2023) The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world study. Annals of Medicine 55:1, pages 1317-1324.
Read now
Read now
Yi Zhang, Naoya Tanabe, Hiroshi Shima, Yusuke Shiraisi, Tsuyoshi Oguma, Atsuyasu Sato, Shigeo Muro, Susumu Sato & Toyohiro Hirai. (2022) Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 149-157.
Read now
Read now
Josef Yayan, Markus Bald & Karl-Josef Franke. (2021) No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years. International Journal of General Medicine 14, pages 2883-2892.
Read now
Read now
Leah B Sansbury, Kieran J Rothnie, Chanchal Bains, Chris Compton, Glenn Anley & Afisi S Ismaila. (2021) Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2591-2604.
Read now
Read now
Zorica Lazic, Ivana Stankovic, Branislava Milenkovic, Biljana Zvezdin, Sanja Hromis, Slobodan Jankovic & Vojislav Cupurdija. (2021) Characteristics of COPD Phenotypes in Serbia. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 643-654.
Read now
Read now
Chen Liang, Xihua Mao, Hongtao Niu, Ke Huang, Fen Dong, Yahong Chen, Kewu Huang, Qingyuan Zhan, Yin Huang, Yaowen Zhang, Ting Yang & Chen Wang. (2021) Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 451-465.
Read now
Read now
Seiichi Kobayashi, Masakazu Hanagama, Masatsugu Ishida, Manabu Ono, Hikari Sato, Shinsuke Yamanda & Masaru Yanai. (2020) Clinical Characteristics and Outcomes of Patients with Asthma–COPD Overlap in Japanese Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2923-2929.
Read now
Read now
Dejan Radovanovic, Marco Contoli, Fabiano Di Marco, Giovanni Sotgiu, Girolamo Pelaia, Fulvio Braido, Angelo Guido Corsico, Claudio Micheletto, Paola Rogliani, Nicola Scichilone, Laura Saderi, Pierachille Santus & Paolo Solidoro. (2019) Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:3-4, pages 215-226.
Read now
Read now
Articles from other publishers (13)
Qing Song, Ling Lin, Wei Cheng, Xue-Shan Li, Yu-Qin Zeng, Cong Liu, Min-Hua Deng, Dan Liu, Zhi-Ping Yu, Xin Li, Li-Bing Ma, Yan Chen, Shan Cai & Ping Chen. (2023) Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMJ Open 13:3, pages e065625.
Crossref
Crossref
Anuj Kumar Pandey, Ajay Kumar Verma, Arpita Singh, Surya Kant, Rakesh Kumar Dixit, Shyam Chand Chaudhary, Jyoti Bajpai, Ved Prakash & Umesh Pratap Verma. (2022) The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease. Cureus.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Crossref
Zichen Ji, Julio Hernández-Vázquez, Marta Esteban-Yagüe, Paula García-Valentín, José María Bellón-Cano, Irene Milagros Domínguez-Zabaleta, Ismael Ali-García, Carmen Matesanz-Ruiz, María Jesús Buendía-García & Javier de Miguel-Díez. (2022) Differences in Survival of Patients With COPD According to the New GesEPOC 2021 Classification of Phenotypes. Open Respiratory Archives 4:4, pages 100212.
Crossref
Crossref
Osamu Usami. (2022) Improved inhaler handling after repeated inhalation guidance for elderly patients with bronchial asthma and chronic obstructive pulmonary disease. Medicine 101:35, pages e30238.
Crossref
Crossref
John R. Hurst, MeiLan K. Han, Barinder Singh, Sakshi Sharma, Gagandeep Kaur, Enrico de Nigris, Ulf Holmgren & Mohd Kashif Siddiqui. (2022) Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respiratory Research 23:1.
Crossref
Crossref
Vasilii D. FedotovA.V. ZhestkovArtem V. LyaminM.I. ZaslavskayaI.S. DobrotinaA.A. Tulichev. (2022) Microbiota in the pathogenesis of COPD and its impact on the course of the disease. Clinical Microbiology and Antimicrobial Chemotherapy 24:3, pages 202-212.
Crossref
Crossref
Jieun Kang, Jae Seung Lee, Sei Won Lee, Jung Bok Lee & Yeon-Mok Oh. (2021) Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials. Respiratory Research 22:1.
Crossref
Crossref
Seiichi Kobayashi, Masakazu Hanagama, Masatsugu Ishida, Manabu Ono, Hikari Sato & Masaru Yanai. (2021) Exhaled nitric oxide: A biomarker for chronic obstructive pulmonary disease. Respiratory Investigation 59:3, pages 364-366.
Crossref
Crossref
Keiji Oishi, Kazuto Matsunaga, Misa Harada, Junki Suizu, Keita Murakawa, Ayumi Chikumoto, Yuichi Ohteru, Kazuki Matsuda, Sho Uehara, Kazuki Hamada, Shuichiro Ohata, Yoriyuki Murata, Yoshikazu Yamaji, Maki Asami-Noyama, Nobutaka Edakuni, Tomoyuki Kakugawa & Tsunahiko Hirano. (2020) A New Dyspnea Evaluation System Focusing on Patients’ Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty. Journal of Clinical Medicine 9:11, pages 3580.
Crossref
Crossref
Elena García Castillo, Tamara Alonso Pérez, Julio Ancochea, Maria Teresa Pastor Sanz, Pere Almagro, Pablo Martínez-Camblor, Marc Miravitlles, Mónica Rodríguez-Carballeira, Annie Navarro, Bernd Lamprecht, Ana S. Ramírez-García Luna, Bernhard Kaiser, Inmaculada Alfageme, Ciro Casanova, Cristóbal Esteban, Juan J. Soler-Cataluña, Juan P. de-Torres, Bartolomé R. Celli, Jose M. Marín, Gerben ter Riet, Patricia Sobradillo, Peter Lange, Judith Garcia-Aymerich, Josep M. Anto, Alice M. Turner, MeiLan K. Han, Arnulf Langhammer, Sigrid Anna Aalberg Vikjord, Alice Sternberg, Linda Leivseth, Per Bakke, Ane Johannessen, Toru Oga, Borja G. Cosío, Andrés Echazarreta, Nicolás Roche, Pierre-Régis Burgel, Don D. Sin, Milo A. Puhan, Jose Luis López-Campos, Laura Carrasco & Joan B. Soriano. (2020) Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data. ERJ Open Research 6:4, pages 00253-2020.
Crossref
Crossref
Yi-Xuan LiaoYa-Hong Chen. (2020) Twenty years of changes in the disease assessment method of the Global Initiative for Chronic Obstructive Lung Disease. Chinese Medical Journal 133:17, pages 2098-2103.
Crossref
Crossref